Femtrace is licensed to treat menopausal symptoms, such as hot flashes and night sweats. This eMedTV Web article offers a complete overview of this drug, including information on how it works, potential side effects, and tips on when and how to take it.
The flu, breast tenderness, and vaginal bleeding are among the most common side effects of Femtrace. This eMedTV Web resource describes other Femtrace side effects, including those that are serious and should be immediately reported to your doctor.
Femtrace is used for treating certain symptoms of menopause, including hot flashes and night sweats. This eMedTV page explores these and other Femtrace uses, including off-label uses (such as treating vaginal symptoms and preventing osteoporosis).
This eMedTV Web article explains that when using Femtrace for menopausal symptoms, it is generally advised to use the lowest effective dose for the shortest possible period of time. The typical starting Femtrace dosage is 0.45 mg once daily.
Certain antibiotics, hypothyroid medications, and seizure medicines may interact with Femtrace. This eMedTV Web page takes an in-depth look at other medications that may cause Femtrace drug interactions and describes the complications that may occur.
You should not use Femtrace if you have liver disease or any cancer that is sensitive to estrogen. This eMedTV page lists other important Femtrace warnings and precautions, including information on what to tell your doctor before taking this drug.
You should seek immediate medical care if you believe you have taken too much Femtrace. This eMedTV resource explains that a Femtrace overdose may cause nausea, vomiting, and vaginal bleeding. This page also describes possible treatment options.
This eMedTV article explains that Femtrace should not be used during pregnancy, as it may cause problems. This page further discusses Femtrace and pregnancy, including why there is no legitimate medical reason to take this medicine when pregnant.
The estrogen hormone in Femtrace does pass through breast milk. This eMedTV Web article explains that although Femtrace is not likely to cause significant problems in a breastfed infant, it may decrease the quality and quantity of breast milk.
Patents currently prevent any generic Femtrace products from being manufactured in the United States. This eMedTV Web resource explains that December 2021 is the earliest expected date that a generic form of the drug could become available.
